1. Immune Checkpoint Inhibition for Unresectable Malignant Pleural Mesothelioma

   • Wanyuan Cui
   • Sanjay Popat

   Current Opinion 09 June 2021 Pages: 971 - 984

2. Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis

   • Tamara Pérez-Jeldres
   • Manuel Alvarez-Lobos
   • Jesús Rivera-Nieves

   Leading Article Open access 13 May 2021 Pages: 985 - 1002

   

3. A Pharmacological and Clinical Overview of Oral Semaglutide for the Treatment of Type 2 Diabetes

   • Andreas Andersen
   • Filip Krag Knop
   • Tina Vilsbøll

   Review Article Open access 08 May 2021 Pages: 1003 - 1030

   

4. Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015–2020

   • Niklas Huntemann
   • Leoni Rolfes
   • Sven G. Meuth

   Review Article Open access 04 June 2021 Pages: 1031 - 1063

   

5. Antimicrobial Lessons From a Large Observational Cohort on Intra-abdominal Infections in Intensive Care Units

   • Dirk Vogelaers
   • Stijn Blot
   • for the Abdominal Sepsis Study (‘AbSeS’) Group on behalf of the Trials Group of the European Society of Intensive Care Medicine

   Review Article 26 May 2021 Pages: 1065 - 1078

6. A Multicentric, Randomized, Controlled Phase III Study of Centhaquine (Lyfaquin^®) as a Resuscitative Agent in Hypovolemic Shock Patients

   • Anil Gulati
   • Rajat Choudhuri
   • Nilesh Radheshyam Agrawal

   Original Research Article Open access 01 June 2021 Pages: 1079 - 1100

   

7. Evinacumab: First Approval

   • Anthony Markham

   AdisInsight Report 18 May 2021 Pages: 1101 - 1105

   

8. Lazertinib: First Approval

   • Sohita Dhillon

   AdisInsight Report Open access 24 May 2021 Pages: 1107 - 1113

   

9. Dasiglucagon: First Approval

   • Hannah A. Blair

   AdisInsight Report 28 May 2021 Pages: 1115 - 1120

   

10. Comment on: “Post-Dialysis Parenteral Antimicrobial Therapy in Patients Receiving Intermittent High-Flux Haemodialysis”

    • Eric Descombes
    • Ould Maouloud Hemett
    • Christian Chuard

    Letter to the Editor 26 May 2021 Pages: 1121 - 1123

11. Comment on: “Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry”

    • Alpo Vuorio
    • Petri T. Kovanen

    Letter to the Editor 28 May 2021 Pages: 1125 - 1127

12. Correction to: Inclisiran: First Approval

    • Yvette N. Lamb

    Correction Open access 13 May 2021 Pages: 1129 - 1129

13. Correction to: Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer

    • Diego Kauffmann-Guerrero
    • Kathrin Kahnert
    • Rudolf M. Huber

    Correction Open access 26 May 2021 Pages: 1131 - 1131

14. Correction to: Nintedanib: A Review in Fibrotic Interstitial Lung Diseases

    • Yvette N. Lamb

    Correction Open access 29 May 2021 Pages: 1133 - 1133